FMO3--TMAO axis modulates the clinical outcome in chronic heart-failure patients with reduced ejection fraction: evidence from an Asian population

{{article.zuoZheEn}}

PDF(864 KB)
PDF(864 KB)
Front. Med. ›› 2022, Vol. 16 ›› Issue (2) : 295-305. DOI: 10.1007/s11684-021-0857-2
RESEARCH ARTICLE

FMO3--TMAO axis modulates the clinical outcome in chronic heart-failure patients with reduced ejection fraction: evidence from an Asian population

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2022, 16(2): 295‒305 https://doi.org/10.1007/s11684-021-0857-2

References

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(864 KB)

Accesses

Citations

Detail

Sections
Recommended

/